Trends in Biochemical Sciences
ReviewMitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Section snippets
Mitochondrial dysfunction in PD
PD is the second most common neurodegenerative disease affecting 1% of the population over the age of 60. The cardinal motor symptoms of PD are a result of the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc; see Glossary) causing a deficiency of dopamine in the striatum. The exact aetiology and natural course of the disease has yet to be fully characterised but involves dysfunction of numerous systems-level processes including mitochondrial function, calcium
PINK1, parkin, and DJ-1 as key mediators of mitochondrial homeostasis and mitophagy
PINK1-dependent activation of parkin is recognised as a major route of mitophagy and is essential for mitochondrial quality control in a number of models; failure of this process results in the persistence of damaged, reactive oxygen species (ROS)-producing, mitochondria, resulting in cellular stress. Recently, significant advances have been made in defining the precise mechanism of PINK1-dependent parkin activation (Box 3). PINK1 activity is primarily regulated by mitochondrial import across
Roles of α-syn aggregation in mitochondrial dysfunction
The aggregation of α-syn and its incorporation as a major component of Lewy bodies is the hallmark of Parkinson's disease. Oligomerisation/aggregation of α-syn in response to oxidation or phosphorylation likely mediates its deleterious effects. Highly penetrant familial mutations or multiplications in the α-syn gene (SNCA) have been shown to cause aggressive early-onset PD. Additionally, a common SNP in the SNCA gene that is enriched in PD patients has been demonstrated to increase expression
The role of increased LRRK2 kinase activity in mitochondrial dysfunction
LRRK 2 is a multifunction protein with important kinase activities; the PD-associated mutation G2019S (kinase domain) is thought to increase kinase activity of the protein [47]. Wild type LRRK2 interacts with a number of key regulators of mitochondrial fission/fusion, co-localising with them either in the cytosol or on mitochondrial membranes, indicating it has multiple regulatory roles (Figure 2) 48, 49. It has been established that in murine primary neurons and human neuroblastoma, endogenous
Novel mitochondrial therapeutic targets
Models of autosomal dominant and autosomal recessive forms of PD demonstrate markedly different mechanisms for the induction of mitochondrial dysfunction and cellular stress. However, the outcomes of this dysfunction – increased ROS production and bioenergetic stress – are common to all forms of mitochondrial dysfunction (Box 1). The wealth of mechanistic information on the mitochondrial functions of PD-related proteins has identified a wide range of points for therapeutic intervention.
Concluding remarks
PD patients with either autosomal dominant or autosomal recessive PD, or models of these mutations, demonstrate mitochondrial complex-I deficiencies, mitochondrial DNA (mtDNA) damage, and oxidative stress. However, as discussed earlier, it is likely that mitochondrial dysfunction in autosomal dominant and autosomal recessive PD does not occur by the same mechanism. Indeed, even from a clinical perspective, autosomal recessive mutations may represent a nigral-specific degeneration (nigropathy)
Acknowledgements
The authors acknowledge funding support from the Monument Discovery Award from Parkinson's UK and Parkinson's UK grants G-0801 and G-1003. E.A.F. is supported by the Canadian Institutes of Health Research (CIHR) and a National Scholar Award from the Fonds de Recherche du Québec Santé (FRSQ).
Glossary
- Autophagy
- a process of degradation of cellular components via breakdown in the lysosome, either by direct import, that is, chaperone mediated autophagy (CMA), or by incorporation into autophagosomes and subsequent lysosomal fusion, that is, micro/macroautophagy.
- GWAS
- genome-wide association studies are used to identify SNPs, which are commonly present in the population, that are associated with a phenotype, for example, an increased risk of developing PD. GWAS can be used as a way of identifying
References (113)
Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson's disease
J. Biol. Chem.
(2011)PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility
Cell
(2011)PINK1 triggers autocatalytic activation of Parkin to specify cell fate decisions
Curr. Biol.
(2014)Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1
Neurosci. Lett.
(2014)- et al.
SG2NA recruits DJ-1 and Akt into the mitochondria and membrane to protect cells from oxidative damage
Free Radic. Biol. Med.
(2014) - et al.
Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption
Redox Biol.
(2014) Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein
Neurobiol. Dis.
(2014)Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells
Biochim. Biophys. Acta
(2014)Soluble, prefibrillar α-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction
J. Biol. Chem.
(2014)Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse
Neurobiol. Dis.
(2014)
alpha-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease
Free Radic. Biol. Med.
The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity
J. Biol. Chem.
Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
Exp. Neurol.
Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells
Mol. Cell. Neurosci.
Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription
Cell
MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond
Biochim. Biophys. Acta
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress
Cell Stem Cell
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression
Cell Stem Cell
G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy
Toxicology
α-Synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration
Cell Rep.
Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
Neurobiol. Dis.
A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1
Cell
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
Neurobiol. Aging
Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins
Free Radic. Biol. Med.
Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies
Mol. Cell. Proteomics
Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
Redox Biol.
Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity
J. Biol. Chem.
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death
Mol. Cell
Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease
J. Biol. Chem.
Mitochondrial complex I deficiency in Parkinson's disease
Lancet
Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease
Neurobiol. Dis.
Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53
J. Biol. Chem.
Short mitochondrial ARF triggers Parkin/PINK1-dependent mitophagy
J. Biol. Chem.
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nat. Genet.
Structure and function of Parkin, PINK1, and DJ-1, the three musketeers of neuroprotection
Front. Neurol.
Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment
EMBO Rep.
PINK1 cleavage at position A103 by the mitochondrial protease PARL
Hum. Mol. Genet.
Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy
EMBO Rep.
The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance
Autophagy
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
Nat. Commun.
The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria
Autophagy
PINK1-phosphorylated mitofusin 2 is a parkin receptor for culling damaged mitochondria
Science
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Nat. Cell Biol.
Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization
Nature
Parkinson's disease-associated kinase PINK1 regulates miro protein level and axonal transport of mitochondria
PLoS Genet.
Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin
J. Cell Biol.
Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function
EMBO Mol. Med.
PINK1 loss of function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling
Science
The complex I subunit NDUFA10 selectively rescues Drosophila pink1 mutants through a mechanism independent of mitophagy
PLoS Genet.
Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson's disease
Cell Death Dis.
Cited by (405)
m6A methyltransferase METTL3 contributes to sympathetic hyperactivity post-MI via promoting TRAF6-dependent mitochondrial ROS production
2023, Free Radical Biology and MedicineAI molecular property prediction for Parkinson's Disease reveals potential repurposing drug candidates based on the increase of the expression of PINK1
2023, Computer Methods and Programs in BiomedicineMitochondrial microRNAs (mitomiRs) in human ageing and diseases
2023, Mechanisms of Ageing and DevelopmentNeuropathogenesis-on-chips for neurodegenerative diseases
2024, Nature CommunicationsSubthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
2024, npj Parkinson's Disease